Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.
作者信息
Dhamoon Mandip S, Elkind Mitchell S V
机构信息
Department of Neurology, Columbia University, New York, NY, USA.
出版信息
Circulation. 2010 May 11;121(18):2071-8. doi: 10.1161/CIRCULATIONAHA.109.921072.
Abstract
摘要
相似文献
1
Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.将中风纳入血管疾病一级和二级预防风险评分的结局及风险等同因素之中。
Circulation. 2010 May 11;121(18):2071-8. doi: 10.1161/CIRCULATIONAHA.109.921072.
2
New guidelines to reduce risk of atherosclerotic cardiovascular disease: implications for stroke prevention in 2014.降低动脉粥样硬化性心血管疾病风险的新指南：2014年对卒中预防的启示
Stroke. 2014 Apr;45(4):945-7. doi: 10.1161/STROKEAHA.114.004560. Epub 2014 Feb 20.
3
The USPSTF recommendation statement on coronary heart disease risk assessment.美国预防医学工作组关于冠心病风险评估的推荐声明。
Ann Intern Med. 2010 Mar 16;152(6):403-4; author reply 405-6. doi: 10.7326/0003-4819-152-6-201003160-00016.
4
The USPSTF recommendation statement on coronary heart disease risk assessment.美国预防服务工作组关于冠心病风险评估的推荐声明。
Ann Intern Med. 2010 Mar 16;152(6):403; author reply 405-6. doi: 10.7326/0003-4819-152-6-201003160-00015.
5
The USPSTF recommendation statement on coronary heart disease risk assessment.美国预防服务工作组关于冠心病风险评估的推荐声明。
Ann Intern Med. 2010 Mar 16;152(6):404-5; author reply 405-6. doi: 10.7326/0003-4819-152-6-201003160-00017.
6
The USPSTF recommendation statement on coronary heart disease risk assessment.美国预防服务工作组关于冠心病风险评估的推荐声明。
Ann Intern Med. 2010 Mar 16;152(6):405; author reply 405-6. doi: 10.7326/0003-4819-152-6-201003160-00018.
7
Therapeutic interventions and success in risk factor control for secondary prevention of stroke.治疗干预和危险因素控制在中风二级预防中的效果。
J Stroke Cerebrovasc Dis. 2009 Nov-Dec;18(6):460-5. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.014.
8
Challenges to the management of high-risk stroke patients with multiple-site occlusive vascular disease.多部位闭塞性血管病变高危卒中患者的管理挑战。
Cerebrovasc Dis. 2011;31(4):315-21. doi: 10.1159/000322603. Epub 2011 Jan 7.
9
The Potential for Postrandomization Confounding in Randomized Clinical Trials.随机临床试验中随机化后混杂因素的可能性。
JAMA. 2016 Jun 7;315(21):2273-4. doi: 10.1001/jama.2016.3676.
10
Guideline-Directed Application of Coronary Artery Calcium Scores for Primary Prevention of Atherosclerotic Cardiovascular Disease.冠状动脉钙化评分在动脉粥样硬化性心血管疾病一级预防中的指南指导应用
JACC Cardiovasc Imaging. 2025 Apr;18(4):465-475. doi: 10.1016/j.jcmg.2024.12.008. Epub 2025 Mar 5.
引用本文的文献
1
Incidence of Acute Myocardial Infarction in Patients Presenting With Cerebrovascular Accident in a Tertiary Care Centre in Eastern India.印度东部一家三级医疗中心中出现脑血管意外的患者急性心肌梗死发病率
Cureus. 2022 Sep 10;14(9):e29005. doi: 10.7759/cureus.29005. eCollection 2022 Sep.
2
Cardiovascular Events After Intracerebral Hemorrhage.脑出血后的心血管事件。
Stroke. 2022 Jul;53(7):2131-2141. doi: 10.1161/STROKEAHA.122.036884. Epub 2022 Jun 8.
3
Psychological and social support associations with mortality and cardiovascular disease in middle-aged American Indians: the Strong Heart Study.中年美国印第安人心血管疾病与死亡的心理和社会支持相关性：美国心脏协会印第安纳波利斯心脏研究。
Soc Psychiatry Psychiatr Epidemiol. 2022 Jul;57(7):1421-1433. doi: 10.1007/s00127-022-02237-7. Epub 2022 Feb 14.
4
Association between systemic sclerosis and peripheral arterial disease: a nationwide observation retrospective claim records cohort study in Taiwan.系统性硬化症与外周动脉疾病的相关性：台湾一项全国性观察性回顾性索赔记录队列研究。
BMJ Open. 2021 Sep 29;11(9):e048149. doi: 10.1136/bmjopen-2020-048149.
5
Coronary Artery Calcium Score Improves the Prediction of Occult Coronary Artery Stenosis in Ischemic Stroke Patients.冠状动脉钙化积分可改善对缺血性脑卒中患者隐匿性冠状动脉狭窄的预测。
J Am Heart Assoc. 2016 Oct 31;5(11):e003770. doi: 10.1161/JAHA.116.003770.
6
Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of Stroke.美国成年人中收缩压干预试验排除组的入选标准患病率：年龄<50岁、患有糖尿病或有中风病史。
J Am Heart Assoc. 2016 Jul 12;5(7):e003547. doi: 10.1161/JAHA.116.003547.
7
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.奥地利代谢性脂质紊乱管理以预防血管并发症的脂质共识：八个医学协会发布的联合立场声明。2016年更新版。
Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S216-28. doi: 10.1007/s00508-016-0993-x.
8
Quantifying the risk of heart disease following acute ischaemic stroke: a meta-analysis of over 50,000 participants.量化急性缺血性中风后心脏病的风险：对超过50000名参与者的荟萃分析。
BMJ Open. 2016 Jan 20;6(1):e009535. doi: 10.1136/bmjopen-2015-009535.
9
Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease.美国高冠心病风险的成年人他汀类药物使用率低且 LDL-C 控制率低。
Am J Med Sci. 2014 Aug;348(2):108-14. doi: 10.1097/MAJ.0000000000000292.
10
Authors' reply.作者回复。
Indian J Endocrinol Metab. 2012 May;16(3):472-3. doi: 10.4103/2230-8210.95720.
本文引用的文献
1
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes.强化降低胆固醇水平预防卒中（SPARCL）试验按卒中亚型划分的结果。
Stroke. 2009 Apr;40(4):1405-9. doi: 10.1161/STROKEAHA.108.534107. Epub 2009 Feb 19.
2
The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years.65岁以上患者中，慢性肾病、糖尿病和心肌梗死作为心血管死亡等效危险因素的情况。
Am J Cardiol. 2008 Dec 15;102(12):1668-73. doi: 10.1016/j.amjcard.2008.07.060. Epub 2008 Oct 23.
3
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.预防动脉疾病和糖尿病进展（POPADAD）试验：糖尿病和无症状外周动脉疾病患者中阿司匹林和抗氧化剂的析因随机安慰剂对照试验。
BMJ. 2008 Oct 16;337:a1840. doi: 10.1136/bmj.a1840.
4
Telmisartan to prevent recurrent stroke and cardiovascular events.替米沙坦预防复发性中风和心血管事件。
N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.
5
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
6
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
7
Telmisartan, ramipril, or both in patients at high risk for vascular events.替米沙坦、雷米普利或两者联合用于血管事件高危患者。
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
8
General cardiovascular risk profile for use in primary care: the Framingham Heart Study.用于初级保健的一般心血管风险概况：弗雷明汉心脏研究
Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
9
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.英国一种新型心血管疾病风险评分QRISK的推导与验证：前瞻性开放队列研究
BMJ. 2007 Jul 21;335(7611):136. doi: 10.1136/bmj.39261.471806.55. Epub 2007 Jul 5.
10
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study.首次缺血性中风后心肌梗死或血管性死亡的风险：北曼哈顿研究
Stroke. 2007 Jun;38(6):1752-8. doi: 10.1161/STROKEAHA.106.480988. Epub 2007 Apr 12.
Zotero 插件